News
Jaguar Health
JAGX · NASDAQ
$2.63−$0.19 (−6.74%)TodayMarket closed ·
Prev close $2.82
Latest news
- NewsAvi Kapoor
Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- Press releaseACCESS Newswire
Jaguar Health Provides Update Regarding Special Stock Dividend
- Press releaseACCESS Newswire
Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
- NewsMohd Haider
Jaguar Health (JAGX) Stock Climbs Over 34% After-Hours: What's Going On?
- Press releaseACCESS Newswire
Jaguar Health Announces a Special Stock Dividend
- NewsHenry Khederian
Jaguar Health Stock Surges Friday: What's Happening?
- NewsHenry Khederian
Jaguar Health Stock Slides Thursday: What's Happening?
- NewsHenry Khederian
Jaguar Health Stock Plunges Wednesday: What's Happening?
- NewsAvi Kapoor
Dow Falls 100 Points; General Mills Posts Upbeat Q1 Earnings
- NewsShivdeep Dhaliwal
Jaguar Health, IONQ, Viking Therapeutics, Xanadu Quantum and Grab Holdings: Why These 5 Stocks Are on Investors' Radars Today
- NewsHenry Khederian
Jaguar Health Stock Slides Thursday: What's Happening?
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
Jaguar Health Reports Q2 2026 Results: Full Earnings Call Transcript
- Press releaseACCESS Newswire
Jaguar Health Reports Second Quarter 2026 Financials
- Press releaseACCESS Newswire
Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates
- News
Jaguar Health’s Napo Pharma Satisfies Conditions Required To Receive Payment Of Non-Dilutive $2M Holdback Amount From Future Pak Related To US Commercial Licensing Agreement
- Press releaseACCESS Newswire
Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsCaroline Ryan
Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Billion, Camp Mystic Bankruptcy
- Press releaseACCESS Newswire
Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
- Press releaseACCESS Newswire
Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseACCESS Newswire
Jaguar Health to Hold Investor Webcast May 26 Regarding Q1 2026 Financials & Corporate Updates; Jaguar CEO Lisa Conte Presenting May 28 at Lytham Partners Spring 2026 Investor Conference
- News
Jaguar Health's Napo Pharmaceuticals Announces That First Patient From Cohort Of Pediatric MVID Patients Has Entered The Active Treatment Only Single-Blind Extension To Study Safety And Efficacy
- Press releaseACCESS Newswire
Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer
- NewsHenry Khederian
Jaguar Health Stock Surges On FDA Breakthrough Discussions For Rare Disease Therapy
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseACCESS Newswire
FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)
- News
Jaguar Health's Napo Pharma Receives $3M Payment From Future Pak Following Termination By Jaguar Of Buy-Back Provision Of U.S. Licensing Agreement; Future Pak To Continue To Commercialize Mytesi Beyond Five Years
- Press releaseACCESS Newswire
Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- Press releaseACCESS Newswire
Reminder: Today, March 2, 2026, is the Record Date for Jaguar Health's Special One-time Stock Dividend
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseACCESS Newswire
Jaguar Health Announces a Special One-time Stock Dividend
- News
Jaguar Health Receives Orphan Drug Designation For Crofelemer In US/EU, Non-Dilutive Funding From Mytesi Out-License, Targeting SBS-IF And MVID As Potential Blockbuster Opportunity
- Press releaseACCESS Newswire
Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releaseACCESS Newswire
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders
- Press releaseACCESS Newswire
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseACCESS Newswire
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue
- News
Jaguar Health's Napo Announces That Initial Proof-Of-Concept Results From Ongoing IIT Show Liquid Formulation Of Crofelemer Reduced Required TPN And Supplementary Intravenous Fluids In Third Intestinal Failure Patient
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.